Sol-Gel Technologies Ltd. (SLGL)
SLGL Stock Price Chart
Explore Sol-Gel Technologies Ltd. interactive price chart. Choose custom timeframes to analyze SLGL price movements and trends.
SLGL Company Profile
Discover essential business fundamentals and corporate details for Sol-Gel Technologies Ltd. (SLGL) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
1 Feb 2018
Employees
34.00
Website
https://www.sol-gel.comCEO
Moshe Arkin
Description
Sol-Gel Technologies Ltd., a pharmaceutical firm currently in its clinical development phase, specializes in the creation and market introduction of skin-applied medications. These products leverage the company's distinctive microencapsulation technology, with their primary development and commercialization activities centered in Israel. Sol-Gel's pipeline features several key candidates. Twyneo, an innovative, non-antibiotic topical cream designed for once-daily application, has successfully concluded Phase III trials for treating acne vulgaris. Similarly, Epsolay, another topical cream administered once a day, has also completed its Phase III studies, targeting papulopustular rosacea. Advancing through Phase I clinical trials is SGT-210, intended for palmoplantar keratoderma. Furthermore, the company is investigating Erlotinib, Tapinarof, and Roflumilast as potential treatments for psoriasis and various other medical conditions. Beyond its proprietary offerings, the company also engages in creating generic versions of topical dermatological medications. Sol-Gel Technologies maintains a strategic partnership with Perrigo. Established in 1997, the company maintains its headquarters in Ness Ziona, Israel.
SLGL Financial Timeline
Browse a chronological timeline of Sol-Gel Technologies Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 21 Aug 2026
EPS estimate is -$3.33, while revenue estimate is $1.20m.
Earnings released on 28 May 2026
EPS came in at -$1.31 surpassing the estimated -$2.86 by +54.20%, while revenue for the quarter reached $108.00k , missing expectations by -88.00%.
Earnings released on 19 Mar 2026
EPS came in at -$1.07 falling short of the estimated $0.39 by -374.36%, while revenue for the quarter reached $6.50m , meeting expectations.
Earnings released on 20 Nov 2025
EPS came in at -$2.13 falling short of the estimated -$2.09 by -1.91%, while revenue for the quarter reached $400.00k , missing expectations by -93.85%.
Earnings released on 15 Aug 2025
EPS came in at $4.17 surpassing the estimated -$0.67 by +722.39%, while revenue for the quarter reached $17.26m , beating expectations by +504.00%.
Stock split effective on 5 May 2025
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 29 Apr 2025
EPS came in at -$2.10 falling short of the estimated -$1.10 by -90.91%, while revenue for the quarter reached $1.03m , missing expectations by -48.45%.
Earnings released on 26 Mar 2025
EPS came in at -$0.21 falling short of the estimated -$0.11 by -90.77%, while revenue for the quarter reached $278.00k , missing expectations by -86.10%.
Earnings released on 15 Nov 2024
EPS came in at -$0.01 surpassing the estimated -$0.13 by +92.31%, while revenue for the quarter reached $5.36m , beating expectations by +168.05%.
Earnings released on 16 Aug 2024
EPS came in at $0.07 surpassing the estimated -$0.20 by +135.00%, while revenue for the quarter reached $5.43m , beating expectations by +417.43%.
Earnings released on 20 May 2024
EPS came in at -$0.23 falling short of the estimated -$0.15 by -53.33%, while revenue for the quarter reached $466.00k , missing expectations by -49.89%.
Earnings released on 13 Mar 2024
EPS came in at -$0.17 falling short of the estimated -$0.16 by -6.25%, while revenue for the quarter reached $447.00k , beating expectations by +65.56%.
Earnings released on 9 Nov 2023
EPS came in at -$0.21 surpassing the estimated -$0.23 by +8.70%, while revenue for the quarter reached $213.00k , missing expectations by -21.11%.
Earnings released on 10 Aug 2023
EPS came in at -$0.22 surpassing the estimated -$0.26 by +15.38%, while revenue for the quarter reached $594.00k , missing expectations by -61.68%.
Earnings released on 12 May 2023
EPS came in at -$0.41 falling short of the estimated -$0.22 by -86.36%, while revenue for the quarter reached $758.00k , beating expectations by +61.28%.
Earnings released on 10 Mar 2023
EPS came in at -$0.25 falling short of the estimated -$0.13 by -92.31%, while revenue for the quarter reached $100.00k , missing expectations by -94.57%.
Earnings released on 10 Nov 2022
EPS came in at -$0.15 falling short of the estimated -$0.07 by -114.29%, while revenue for the quarter reached $261.00k , missing expectations by -92.38%.
Earnings released on 4 Aug 2022
EPS came in at -$0.01 surpassing the estimated -$0.10 by +90.00%, while revenue for the quarter reached $3.52m , missing expectations by -23.68%.
Earnings released on 13 May 2022
EPS came in at -$0.24 surpassing the estimated -$0.30 by +20.00%, while revenue for the quarter reached $3.00k , missing expectations by -99.78%.
Earnings released on 30 Mar 2022
EPS came in at $0.61 surpassing the estimated $0.41 by +48.78%, while revenue for the quarter reached $20.81m , beating expectations by +17.86%.
Earnings released on 11 Nov 2021
EPS came in at $0.05 surpassing the estimated -$0.07 by +171.43%, while revenue for the quarter reached $8.84m , missing expectations by -62.96%.
Earnings released on 4 Aug 2021
EPS came in at -$0.35 falling short of the estimated -$0.20 by -75.00%, while revenue for the quarter reached $928.00k , beating expectations by +7.74%.
SLGL Stock Performance
Access detailed SLGL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
